2023-05-15T09:46:44-05:00 2022-12-31 341874260 CBIZ MHM LLC 700 WEST 47TH STREET SUITE 1100 KANSAS CITY MO 64112 990 2022-01-01 431889037 BIONEXUS KC BION 8167537700 30 W PERSHING ROAD 210 KANSAS CITY MO 64108 DENNIS RIDENOUR PRESIDENT & CEO 8167537700 2023-05-15 1 DENNIS RIDENOUR XXX-XX-XXXX 0 LISA BURKE P00220718 8169455500 2023-05-09 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z DENNIS RIDENOUR 30 W PERSHING ROAD 210 KANSAS CITY MO 64108 2003138 0 X WWW.BIONEXUSKC.ORG X 2000 MO BIONEXUS KC IS USING LIFE SCIENCES INNOVATION AND COLLABORATION TO ADDRESS SOME OF THE BIGGEST CHALLENGERS, ENSURING A HEALTHIER AND MORE PROSPEROUS FUTURE FOR ALL. 13 12 6 43 0 0 1502179 1172982 131053 120756 -669 6866 -11015 -51178 1621548 1249426 417333 149999 0 0 841824 853058 0 0 25865 347058 392149 1606215 1395206 15333 -145780 1271065 1124416 0 0 1271065 1124416 X WE INSPIRE THINKERS FROM DIFFERENT DISCIPLINES TO COMBINE THEIR EFFORTS FOR A COMMON PURPOSE HEALTHCARE INNOVATION. FROM BIOINFORMATICS TO CANCER RESEARCH AND BEYOND, WE STIMULATE COLLABORATION AND HELP BRING EMERGING TECHNOLOGIES FROM CONCEPT TO REALITY.THE KC REGION IS A GLOBAL LEADER AT THE NEXUS OF HUMAN AND ANIMAL HEALTH BENEFITING ALL OUR CITIZENS AND THE ECONOMY. OUR MISSION IS TO HIGHLIGHT LIFE SCIENCES RESOURCES AND THEIR VALUE TO THE COMMUNITY THROUGH COLLABORATION AND COMMERCIALIZATION. BIONEXUS KC CREATES OPPORTUNITIES AT THE NEXUS OF:-HUMAN AND ANIMAL HEALTH-URBAN AND RURAL HEALTH-ACADEMIA AND INDUSTRY-KANSAS AND MISSOURI 0 0 1069230 149999 129710 SEE SCHEDULE O 1069230 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 5 0 6 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 X 13 12 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 X X SHARON NEWMAN 8167537700 30 W PERSHING ROAD STE 210 KANSAS CITY MO 64108 DENNIS RIDENOUR PRESIDENT & CEO 40.00 X X 229315 0 32665 ANTHONY A SIMPSON MANAGING DIRECTOR, KC NEXU 20.00 X 146030 0 0 DANIEL KENNEDY VICE PRESIDENT 40.00 X 115273 0 16043 WILLIAM S BERKLEY DIRECTOR (CHAIR) 1.00 X X 0 0 0 JEFF HARGROVES DIRECTOR (TREASURER & SECRETARY) 1.00 X X 0 0 0 DONALD CRAIG BRATER DIRECTOR 0.01 X 0 0 0 DAVID FRANTZE DIRECTOR 0.20 X 0 0 0 IRVINE O HOCKADAY JR DIRECTOR 0.30 X 0 0 0 MADELEINE M MCDONOUGH DIRECTOR 0.20 X 0 0 0 THOMAS SACK PHD DIRECTOR 0.20 X 0 0 0 ANNE D ST PETER DIRECTOR 0.20 X 0 0 0 MARIA STECKLEIN FLYNN DIRECTOR 0.50 X 0 0 0 SANDRA STITES MD DIRECTOR 0.20 X 0 0 0 GREG SWEAT MD DIRECTOR 0.20 X 0 0 0 DEBORAH WILKERSON DIRECTOR 0.20 X 0 0 0 490618 0 48708 3 0 1 0 0 128407 116729 927846 1172982 EDA B2S PROGRAM AWARDS 541900 120756 120756 120756 7492 7492 650325 650000 951 325 -951 -626 -626 42629 128407 102761 -60132 -60132 MISCELLANEOUS REVENUE 541900 8954 8954 8954 1249426 129710 0 -53266 149999 149999 393297 268677 109804 14816 350797 268751 80256 1790 60307 39668 19375 1264 48657 32005 15633 1019 44450 44450 19577 19577 102394 96173 350 5871 22598 22055 543 25917 20591 5199 127 15985 11888 3975 122 46680 33759 12454 467 11016 11016 22425 16653 5705 67 4911 3241 1572 98 STEAM AWARDS/HONORARIA 30548 30548 MEMBERSHIPS AND DUES 24612 15572 8855 185 MISCELLANEOUS 17139 1963 15176 LIFE SCIENCES CENSUS 3897 2221 1637 39 1395206 1069230 300111 25865 1256236 1109943 105987 91514 14829 14473 0 1271065 1124416 0 0 X 901988 893639 369077 230777 1271065 1124416 1271065 1124416 -145780 -869 0 X X 0 1 X 1 0 X 1667012 1561392 992550 1502179 1172982 6896115 1667012 1561392 992550 1502179 1172982 6896115 3081244 3814871 27434 28028 20513 137 7492 83604 106 32151 100 7260 8954 48571 7028290 0.54280 0.49880 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 668 668 1068562 1069230 181923 45481 0 0 213305 194980 202190 181923 792398 1188597 1414 1167 600 668 3849 53326 48745 50548 45481 198100 297150 55730 48257 7473 50257 43257 7000 14473 X 1265555 -869 -8954 25952 16129 1249426 0 1249426 1412204 16998 16998 1395206 0 1395206 PART X, LINE 2: BIONEXUS KC HAS BEEN GRANTED EXEMPTION FROM INCOME TAXES BY THE INTERNAL REVENUE SERVICE UNDER THE PROVISIONS OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THERE WAS NO UNRELATED BUSINESS INCOME DURING THE 2022 OR 2021 TAX YEAR. THE ORGANIZATION HAS EVALUATED THE STANDARDS REQUIRING DISCLOSURE OF UNCERTAIN TAX POSITIONS AND DETERMINED THAT THERE ARE NO MATERIAL MATTERS WHICH REQUIRE DISCLOSURE. PART XI, LINE 2D - OTHER ADJUSTMENTS: EVENT EXPENSES 25,952. PART XII, LINE 2D - OTHER ADJUSTMENTS: RECOVERY OF GRANT REIMBURSEMENTS -8,954. EVENT EXPENSES 25,952. ANNUAL DINNER 112309 75938 36371 2448 22009 37028 500 15059 INFORMATICS CONFERENCE 17611 15423 2188 11475 4 41116 37046 4070 2331 11807 104 171036 128407 42629 2448 24340 60310 500 15163 102761 -60132 1 UNIVERSITY OF MISSOURI 115 BUSINESS LOOP 70W MIZZOU NH RM 501 COLUBMIA MO 65211 436003859 170(B)(1)(A)(II) 50000 0 BIONEXUS KC 20-1 PATTON TIMOTHY COX, PHD UMKC; BIONEXUS KC 20-4 NEXUS OF ANIMAL AND HUMAN HEALTH RESEARCH GRANT JOAN COATES; BIONEXUS KC 20-6 NEXUS OF ANIMAL AND HUMAN HEALTH RESEARCH GRANT EMMA MEYER CHILDREN'S MERCY HOSPITAL 2401 GILLHAM RD KANSAS CITY MO 64108 440605373 501(C)(3) 49999 0 BIONEXUS KC 22-5 PATTON SCOTT YOUNGER, PHD UNIVERSITY OF KANSAS CENTER FOR RESEARCH 2385 IRVING HILL RD LAWRENCE LAWRENCE KS 66045 480680117 501(C)(3) 50000 0 BIONEXUS KC 20-4 PATTON TRUST RESEARCH GRANT, PAMELA TRAN,, PHD 3 PART I, LINE 2: GRANTS ARE FOR A ONE YEAR DURATION. GRANT RECIPIENTS AGREE TO PROVIDE A PROGRESS REPORT AT SIX MONTHS AND A SUMMARY TECHNICAL PROGRESS REPORT WITHIN 30 DAYS OF THE END OF THE PERFORMANCE TO INCLUDE: 1. A BRIEF SUMMARY OF TECHNICAL PROGRESS RELATIVE TO THE GOALS AND OBJECTIVES PROPOSED IN THE PROPOSAL. 2. A BRIEF STATEMENT CONCERNING THE EFFECTIVENESS AND BENEFITS REALIZED FROM THE COLLABORATIONS INVOLVED. GRANT RECIPIENTS AGREE TO PROVIDE (UPON REQUEST) A COPY OF ALL PROPOSALS SUBMITTED TO EXTERNAL FUNDING AGENCIES AS A RESULT OF THE SUPPORT PROVIDED AND SUBSEQUENTLY NOTIFY BIONEXUS KC OF ACCEPTANCE OR REJECTION THEREOF. IF THE GRANT RECIPIENT RECEIVES ALTERNATIVE FUNDS FOR SUPPORT OF THIS SPECIFIC PROJECT, BIONEXUS KC REQUESTS THAT THE RECIPIENT RETURN ANY UNEXPENDED FUNDS TO THE INSTITUTE SO THAT THEY CAN BE USED TO SUPPORT OTHER INVESTIGATORS. X X X X 0 0 0 0 0 0 0 0 0 DENNIS RIDENOUR PRESIDENT & CEO 209315 0 20000 0 0 0 21269 0 11396 0 261980 0 0 0 FORM 990, PART III, LINE 4A 2022 ACCOMPLISHMENTS: 1. REGIONAL LIFE SCIENCES STRATEGIC ASSESSMENT "PATH TO 2025" 2. 2021 KANSAS CITY REGIONAL LIFE SCIENCES CENSUS 3. KANSAS CITY QUALITY AND VALUE INNOVATION CONSORTIUM (KC QVIC)/HEALTHCARE INSTITUTE FOR INNOVATIONS IN QUALITY (HI-IQ) 4. KANSAS CITY REGIONAL BIOLOGICS RESEARCH AND DEVELOPMENT INVENTORY 5. ETHICAL ARTIFICIAL INTELLIGENCE (AI) 6. HEALTH EQUITY LEARNING AND ACTION NETWORK (HE-LAN) 7. DIVERSITY, EQUITY AND INCLUSION (DEI) 8. RESEARCH DEVELOPMENT GRANT PROGRAMS 9. KC NEXUS FUND 10. WORKFORCE DEVELOPMENT 11. FOCUS FORWARD ON THE FUTURE OF KC 12. "SCIENCE2ART" 13. EVENTS: -NEXUS INFORMATICS -ONE HEALTH DAY 14. SOCIAL MEDIA -CONNECTION -EXPERT EXCHANGE 1. REGIONAL LIFE SCIENCES STRATEGIC ASSESSMENT: "PATH TO 2025" THE PATH TO 2025, A 10-YEAR STRATEGIC ROADMAP FOR THE KC REGION WAS DEVELOPED COLLABORATIVELY WITH THE COMMUNITY IN 2015. NEARLY EIGHT YEARS IN, THE REPORT REMAINS THE LENS BIONEXUS KC APPLIES TO ITS WORK AND PRIORITY FOCUS AREAS. THIS REPORT HIGHLIGHTS SCIENTIFIC FOCUS AREAS OF OPPORTUNITY, INCLUDING ANIMAL HEALTH, HEALTH IT AND OUTCOMES RESEARCH, CANCER AND NEUROSCIENCE, AS WELL AS COMPONENTS OF THE REGIONAL INFRASTRUCTURE THAT NEEDED TO BE STRENGTHENED TO ALLOW FOR ROBUST REGIONAL GROWTH, INCLUDING COLLABORATION, CAPITAL, WORKFORCE DEVELOPMENT AND MESSAGING/MARKETING. IN 2022, THE FOUR SCIENTIFIC AREAS CONTINUED TO BE ADVANCED AREAS OF EXPERTISE AND OPPORTUNITY. THE KU CANCER CENTER, A REGIONAL, COLLABORATIVE EFFORT IN WHICH BIONEXUS KC PLAYED AN IMPORTANT ROLE EARLY ON, WAS AWARDED NCI COMPREHENSIVE CANCER CENTER DESIGNATION, A HIGHLY COVETED RECOGNITION THAT WILL EXPAND RESEARCH, ACCESS, AND IMPACT TO PATIENTS ACROSS THE COUNTRY. IN HEALTHCARE IT, BIONEXUS KC CATALYZED THE CREATION OF AN INITIATIVE AROUND DIGITAL HEALTH TO SOLVE HEALTHCARE'S BIGGEST CHALLENGES AND CONNECT IDEAS, TALENT, CAPITAL, AND COMPANIES TO MAKE IMPACTFUL ADVANCEMENTS. THE PATH TO 2025 CONTINUED TO EVOLVE AND NEW PRIORITIES WERE IDENTIFIED BY REGIONAL PARTNERS INCLUDING HEALTH EQUITY, DEI (DIVERSITY, EQUITY, AND INCLUSION), RARE DISEASE AND BIOLOGICS, WHICH CUT ACROSS ALL FOUR SCIENTIFIC AREAS AND ARE NOW KEY AREAS OF FOCUS. WHILE ANIMAL HEALTH IS NOT DIRECTLY CALLED OUT IN THESE NEW AREAS OF OPPORTUNITY, THE REGION CAN LEVERAGE ITS LONGSTANDING STRENGTHS TO DEVELOP UNIQUE ASSETS AND PERSPECTIVES TO ACCELERATE INNOVATION FOR BOTH HUMAN AND ANIMAL PATIENTS. COLLABORATING AND CONVENING THE REGION IN UNIQUE AND EFFECTIVE WAYS REMAINED A FOCAL POINT FOR BIONEXUS KC. THE INSTITUTIONAL ADVISORY COMMITTEE, LIFE SCIENCES COMMUNICATORS, AND DEI COMMITTEE UNITED STAKEHOLDERS AND IDENTIFIED JOINT OPPORTUNITIES. REGIONAL EVENTS, POWERED BY BIONEXUS KC, REPRESENTED KEY GATHERINGS OF RESEARCHERS AROUND PRIORITY TOPICS SHOWCASING REGIONAL STRENGTHS. BIONEXUS KC CULTIVATED A DYNAMIC ECOSYSTEM WITH UNIQUE PARTNERSHIPS TO ADVANCE REGIONAL EFFORTS AND ENSURE THAT 2023 WILL YIELD SIGNIFICANT PROGRESS IN CAPITAL FORMATION, WORKFORCE DEVELOPMENT, AND MARKETING AND MESSAGING. 2. 2021 KANSAS CITY REGIONAL LIFE SCIENCES CENSUS SINCE 2003, BIONEXUS KC HAS COMMISSIONED THE KANSAS CITY REGIONAL LIFE SCIENCES INDUSTRY CENSUS EVERY THREE YEARS TO DEFINE THE COMPOSITION AND SCOPE OF ECONOMIC ACTIVITY IN THIS VITAL SECTOR OF THE ECONOMY. THE UPDATED DATA PROVIDES INSIGHTS THAT CAN INFLUENCE POLICY MAKING, WORKFORCE DEVELOPMENT, AND AREA FUNDING. MOST IMPORTANTLY, IT HELPS IDENTIFY ECONOMIC AND RESEARCH TRENDS THAT WILL HELP STEER THE KC REGION TOWARDS LIFE SCIENCES SUCCESS. THE MOST RECENT VERSION OF THE CENSUS WAS COMPLETED IN DECEMBER 2021 AND FOUND THAT, ACROSS THE 286 COMPANIES IDENTIFIED, THE KC LIFE SCIENCES INDUSTRY EMPLOYS ~35,000 PEOPLE. THE NUMBER OF UNIVERSITY RESEARCH CENTERS ROSE TO 149 IN 2021, AND THE NUMBER OF MEDICAL CENTERS PERFORMING CLINICAL TRIALS INCREASED TO 32. THE FINAL REPORT WAS RELEASED IN JANUARY 2022 AND IS AVAILABLE FOR DOWNLOAD AT TTPS://BIONEXUSKC.ORG/REPORTS/. 3. KANSAS CITY QUALITY AND VALUE INNOVATION CONSORTIUM (KC QVIC) AND THE HEALTHCARE INSTITUTE FOR INNOVATIONS IN QUALITY (HI-IQ) BIONEXUS KC CONTINUED ITS LONGSTANDING SUPPORT OF THE KANSAS CITY QUALITY AND VALUE INNOVATION CONSORTIUM (KC QVIC) WHICH HELPED TRANSITION THE KC QVIC FROM A VISION OF IMPROVING THE EQUITY AND VALUE OF HEALTHCARE IN KANSAS CITY AND REBRANDING AS A NEW UNIT AT UMKC, CALLED THE UMKC HEALTHCARE INSTITUTE FOR INNOVATIONS IN QUALITY (HI-IQ). WITH THE RESOURCES PROVIDED BY BIONEXUS KC, HI-IQ'S TWO TRANSLATIONAL SCIENCE PILOT PROJECTS CONTINUED TO COLLECT VALUABLE, ACTIONABLE INFORMATION. THE PILOT PROJECTS INCLUDED (1) ADDRESSING OPIOID CRISES IN THE EMERGENCY DEPARTMENT AND (2) IMPROVING TRANSITIONS OF CARE FOR HEART FAILURE. BIONEXUS KC PARTICIPATED ON HI-IQ'S STRATEGIC ADVISORY BOARD AND LENT STAFF EXPERTISE TO SUPPORT HI-IQ'S EFFORTS, INCLUDING THE INSTITUTE'S MONTHLY INNOVATIONS IN QUALITY FORUMS (IQ FORUMS). IN 2022, THESE FORUMS ENGAGED OVER 600 REGISTRANTS ON A WIDE VARIETY OF TOPICS INCLUDING: (1) SOCIAL DETERMINANTS OF HEALTH, (2) MATERNAL MORTALITY, (3) RURAL HEALTH AND (4) ALTERNATIVE PAYMENT MODELS. HI-IQ LEVERAGED THE NEARLY $80,000 START-UP GRANT FROM BIONEXUS KC (2021 BIONEXUS KC GRANT) TO SECURE ANOTHER $1.1 MILLION IN GRANT AND PHILANTHROPIC SUPPORT FOR RESEARCH PROJECTS AND LAUNCHED A GRADUATE-LEVEL IMPLEMENTATION SCIENCE COURSE AT UMKC. 4. KANSAS CITY REGIONAL BIOLOGICS RESEARCH AND DEVELOPMENT INVENTORY BIONEXUS KC RECEIVED FUNDING FROM THE KAUFFMAN FOUNDATION TO DEVELOP A REGIONAL ASSESSMENT TO IDENTIFY AND INVENTORY REGIONAL LIFE SCIENCES ORGANIZATIONS PERFORMING RESEARCH AND DEVELOPMENT IN BIOLOGICS TO CREATE A BASELINE TO MEASURE FUTURE GROWTH. THE ASSESSMENT IDENTIFIED NEARLY 120 REGIONAL COMPANIES PERFORMING RESEARCH AND DEVELOPMENT IN BIOLOGICS. THESE COMPANIES ARE PRIMARILY HUMAN HEALTH COMPANIES AND EMPLOY MORE THAN 13,000 PEOPLE ACROSS THE REGION. REGIONAL OPPORTUNITIES WERE IDENTIFIED IN SPECIFIC TECHNOLOGY SECTORS: (1) VACCINES, (2) THERAPEUTIC PROTEINS, (3) CELL/GENE THERAPIES, AND (4) DIAGNOSTICS. IN 2022, KANSAS CITY WAS SELECTED AS ONE OF NINE REGIONS WORLDWIDE TO BE PART OF THE MIT REGIONAL ENTREPRENEURSHIP ACCELERATION PROGRAM (MIT REAP). THE TWO-YEAR PROGRAM ACCELERATES INNOVATION DRIVEN ENTREPRENEURSHIP IN EACH RESPECTIVE INNOVATION ECOSYSTEM. ALONG WITH ORGANIZATIONS FROM ACROSS THE BI-STATE REGION, BIONEXUS KC WAS SELECTED AS A MEMBER OF THE KANSAS CITY MIT REAP TEAM, ULTIMATELY FOCUSED ON BUILDING OUT THE ENTREPRENEURIAL INFRASTRUCTURE TO PROMOTE BIOLOGICS CLUSTER DEVELOPMENT. KANSAS CITY TEAM MEMBERS ATTENDED WORKSHOPS IN BOSTON TO COLLABORATE WITH MIT EXPERTS AND OTHER GLOBAL MIT REAP TEAMS. THESE WORKSHOPS RESULTED IN A REGIONAL STRATEGY TO IDENTIFY NECESSARY ACTIONS AND NEXT STEPS TO GROW THE BIOLOGICS SECTOR AND SECURE SUPPORT FROM ACROSS THE COMMUNITY. 5. ETHICAL AI THE POTENTIAL IMPACT OF ARTIFICIAL INTELLIGENCE (AI) INTEGRATION IS ENORMOUS AS OUR HEALTHCARE SYSTEM WORKS TO PROVIDE CARE FOR MORE PATIENTS WITH FEWER RESOURCES AND CONTINUES TO ADJUST TO THE DYNAMIC REIMBURSEMENT AND REGULATORY LANDSCAPE. MANY SIGNIFICANT CONCERNS AROUND USING AI IN HEALTHCARE DECISION-MAKING REMAIN, INCLUDING BIAS AND DISCRIMINATION, A LACK OF TRANSPARENCY, AND DATA PRIVACY CONCERNS. A NATIONALLY RECOGNIZED KANSAS CITY ORGANIZATION AND A KEY BIONEXUS KC PARTNER, THE CENTER FOR PRACTICAL BIOETHICS, IS LEADING AN ETHICAL AI PROJECT TO CREATE BEST PRACTICES FOR ETHICAL ADHERENCE IN THE DEVELOPMENT, DISSEMINATION, AND USE OF AI SYSTEMS FRAMEWORK. BIONEXUS KC HAS BEEN INVOLVED WITH THE AI PROJECT SINCE IT LAUNCHED IN 2019. AS A FOUNDING MEMBER OF THE ETHICAL AI ADVISORY BOARD, BIONEXUS KC HAS SIGNIFICANTLY GUIDED AND SHAPED THE INITIATIVE. THROUGHOUT 2022, BIONEXUS KC PARTICIPATED IN MONTHLY ADVISORY BOARD MEETINGS AND PARTICIPATED IN A TWO-DAY STRATEGIC PLANNING RETREAT FOCUSED ON FORMALIZING ITS VISION AND MISSION. THE ETHICAL AI PROJECT WILL CURATE AND CREATE CONTENT TO INITIALLY SERVE AS A FOUNDATIONAL LIBRARY OF RESOURCES FOR HEALTHCARE IT COMPANIES AND OTHER STAKEHOLDERS. THE PROJECT WILL ADVANCE THE RESPONSIBLE CREATION AND THOUGHTFUL INTEGRATION OF AI TOWARD POSITIVE AND EQUITABLE HEALTH OUTCOMES. 6. HEALTH EQUITY LEARNING AND ACTION NETWORK (HE-LAN) THE KC HEALTH EQUITY LEARNING AND ACTION NETWORK (KC HE-LAN) UNITED THE REGIONAL HEALTHCARE ECOSYSTEM TO ADDRESS THE FACTORS THAT LEAD TO HEALTH ACCESS, TREATMENT, AND OUTCOME INEQUALITIES. ULTIMATELY, THE KC HELAN WILL CATALYZE EQUITY-CENTERED AND CULTURALLY RESPONSIVE ACTION TO YIELD EQUITABLE HEALTH OUTCOMES FOR ALL. IN 2022, BIONEXUS KC PARTICIPATED IN THE KC HE-LAN DESIGN TEAM TO DEFINE THE NETWORK'S ACTIVITIES AND DELIVERABLES. AS PART OF THE REVIEW TEAM, BIONEXUS KC HELPED IDENTIFY THE PROPOSALS THAT WERE SELECTED TO PARTICIPATE IN THE ACTION PHASE. COMMON TO ALL 15 PROJECTS AND TEAMS WAS A WILLINGNESS TO: (A) ADVANCE EQUITY AND ADDRESS RACISM EXPLICITLY, FORM 990, PART III, LINE 4A (B) SHARE DATA AND LEARNINGS TRANSPARENTLY, AND (C) SUPPORT PARTICIPATING ORGANIZATIONS. THE KC HE-LAN ASSERTED A COMMON AGENDA ACROSS THE REGION AND PROVIDED COMMUNITY TRAINING, TOOLS, AND EXPERTISE. WITH THE TRANSITION TO THE ACTION PHASE, THE WORK SHIFTED TO OUTCOME-ORIENTED PROJECTS THAT WILL IMPLEMENT MEANINGFUL CHANGES TO SYSTEMS, POLICIES, AND STRUCTURES TO REDUCE AND ELIMINATE DISPARITIES IN HEALTHCARE DELIVERY. THIS PHASE WILL IGNITE MEASURABLE IMPROVEMENTS IN HEALTH OUTCOMES, PARTICULARLY AMONG PEOPLE IMPACTED BY HEALTH INEQUITIES. 7. DEI THE PATH TO 2025 CONTINUED TO EVOLVE AND NEW PRIORITIES WERE IDENTIFIED BY REGIONAL PARTNERS. ONE PRIMARY FOCUS OF MANY REGIONAL ORGANIZATIONS IS HEALTH EQUITY AND DIVERSITY, EQUITY, AND INCLUSION (DEI) INITIATIVES. THE ROLE OF BIONEXUS KC IS TO IMPROVE OUTCOMES FOR ALL AND REDUCE THE INEQUITIES THAT EXIST BETWEEN WHITE AND BLACK KANSAS CITIANS. SCIENTIFIC PRIORITY AREAS OF OPPORTUNITY LIKE RARE DISEASE AND BIOLOGICS CUT ACROSS ALL FOUR SCIENTIFIC AREAS ORIGINALLY INCLUDED AND ARE NOW KEY AREAS OF FOCUS. IN 2022 BIONEXUS KC EXPANDED THE DEI COMMITTEE, COMPOSED OF DEI LEADERS FROM BIONEXUS KC STAKEHOLDER INSTITUTIONS. THE BIONEXUS KC DEI COMMITTEE WILL SERVE AS AN ADVISORY BODY TO REGIONAL HEALTHCARE AND LIFE SCIENCE LEADERSHIP, OFFERING GUIDANCE IN THESE AREAS AS REQUESTED. THE BIONEXUS KC DEI COMMITTEE WILL ALSO INTEGRATE BEST PRACTICES FOR DIVERSITY, EQUITY, AND INCLUSION INTO REGIONAL STAKEHOLDER POLICIES AND PROGRAMS. ADDITIONALLY, THE BIONEXUS KC DEI COMMITTEE WILL PROVIDE EDUCATION AND ENRICHMENT OPPORTUNITIES FOR ITS MEMBERS AND SERVES AS A FORUM FOR DISCUSSION OF SUBSTANTIVE BEST PRACTICES. 8. BIONEXUS KC RESEARCH GRANTS PROGRAM THE BIONEXUS KC RESEARCH GRANTS PROGRAM ACCELERATES REGIONAL LIFE SCIENCES AND HEALTHCARE INNOVATION BY HELPING RESEARCHERS DEMONSTRATE PROOF OF CONCEPT FOR EARLY-STAGE WORK. THE PROGRAM LEVERAGES PARTNERSHIPS WITH FUNDERS AND PROVIDES APPLICANTS WITH THE REVIEW INFRASTRUCTURE BUILT BY BIONEXUS KC FOR RESEARCHERS TO GENERATE PRELIMINARY DATA TO DEVELOP COMPETITIVE GRANT PROPOSALS FOR LARGER FUNDING OPPORTUNITIES. THE PROGRAM BOASTS AN INCREDIBLE RECORD OF SUCCESS FOR EVERY $1 GIVEN OUT IN GRANTS, MORE THAN $13.10 IS RETURNED TO THE REGION IN FOLLOW ON FUNDING. OVER TWO DECADES, BIONEXUS KC HAS PROVIDED MORE THAN $6.7 MILLION IN RESEARCH GRANTS, RESULTING IN MORE THAN $91.8 MILLION OF NEW EXTERNAL RESEARCH FUNDING TO THE REGION. IN 2022, BIONEXUS KC PARTNERED WITH THE PAUL PATTON TRUST, TED C. MCCARTER, WILLIAM EVANS, JR, AND BANK OF AMERICA, N.A. TRUSTEE TO AWARD TWO RESEARCH GRANTS FOCUSED ON THE GENETIC BASIS OF DISEASES THAT AFFECT CHILDREN. BIONEXUS KC ALSO CONTINUED ITS LONG-RUNNING PARTNERSHIP WITH BLUE KC AND ADMINISTERED A ONE-YEAR GRANT TO CONFRONT INEQUITIES IN MATERNAL HEALTHCARE QUALITY AND BIRTH OUTCOMES. THE 2022 BIONEXUS KC RESEARCH DEVELOPMENT GRANT PORTFOLIO INCLUDED: THE BLUE KC TRANSFORMING KC HEALTH RESEARCH GRANT PROGRAM: - ANGELA MARTIN, MD, MEDICAL DIRECTOR, LABOR AND DELIVERY, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, UNIVERSITY OF KANSAS MEDICAL CENTER. DR. MARTIN AND HER TEAM WILL SCREEN BLACK PATIENTS RECEIVING PRENATAL CARE AT THE UNIVERSITY OF KANSAS HEALTH SYSTEM FOR RISK FACTORS THAT INCREASE THEIR RISK OF A POOR BIRTH OUTCOME. THESE RISK FACTORS WILL BE RANDOMIZED, AND THE PATIENTS WILL RECEIVE STANDARD PRENATAL OR DOULA-ENHANCED CARE. MARTIN AND HER TEAM WILL COMPARE RESULTS BETWEEN THESE PATIENTS IN ROUTINE PRENATAL CARE AND DOULA CARE TO RESEARCH WHETHER DOULAS IMPROVE CARE QUALITY AND REDUCE ADVERSE EFFECTS. PAUL PATTON CHARITABLE TRUST GRANTS: - PAMELA TRAN, PHD, ASSOCIATE PROFESSOR, ANATOMY AND CELL BIOLOGY, UNIVERSITY OF KANSAS MEDICAL CENTER. DR. TRAN AND HER TEAM WILL EXAMINE THE BIOLOGICAL PROCESSES OF BONE DEVELOPMENT TO DETERMINE WHICH GENES ARE DEFECTIVE AND LEAD TO DEVELOPING SMALL JAW, A COMMON CRANIOFACIAL ABNORMALITY. THE TEAM WILL ALSO EXPLORE WHETHER VARIANTS IN TWO SPECIFIC GENES CO-OCCUR IN CHILDREN WITH CRANIOFACIAL DEFECTS. - SCOTT YOUNGER, PHD, DIRECTOR OF DISEASE GENE ENGINEERING, DEPARTMENT OF PEDIATRICS, GENOMIC MEDICINE CENTER, CHILDREN'S MERCY KANSAS CITY. DR. YOUNGER AND HIS TEAM WILL DEVELOP HIGH-THROUGHPUT EXPERIMENTAL TECHNOLOGIES FOR EVALUATING THE MOLECULAR CONSEQUENCES OF GENETIC VARIANTS AT SCALE. HIS TEAM WILL UTILIZE THESE TECHNOLOGIES TO PROFILE RARE GENETIC VARIANTS IDENTIFIED AT THE CHILDREN'S MERCY RESEARCH INSTITUTE THROUGH ITS GENOMIC ANSWERS FOR KIDS PROGRAM. 9. KC NEXUS FUND THE KC NEXUS FUND IS A PRIVATELY FUNDED, PROFESSIONALLY MANAGED LIFE SCIENCES PROOF OF CONCEPT FUND THAT FILLS A CRITICAL GAP IN THE REGIONAL ENTREPRENEURIAL ECOSYSTEM. THE DEMAND FOR CAPITAL AND SUPPORT FOR REGIONAL LIFE SCIENCES ENTREPRENEURS CONTINUES TO GROW. AS THE IMPACTS OF THE RECESSION HAVE STRAINED GOVERNMENT PROGRAMS AND RESOURCES, START-UPS HAVE STRUGGLED TO FIND THE CAPITAL NECESSARY TO ADVANCE THEIR INNOVATIONS. INSTITUTIONAL INVESTORS ARE TAKING LESS TECHNOLOGY RISK AND FOCUSING ON EXISTING PORTFOLIO COMPANIES, LEAVING LESS CAPITAL TO ADVANCE EARLY CONCEPTS. START-UPS AND INVESTORS CONTINUE TO LOOK TO BIONEXUS KC AND THE KC NEXUS FUND FOR ASSISTANCE AND GUIDANCE TO NAVIGATE THESE CHALLENGES. IN 2022, THE KC NEXUS FUND MADE PROGRESSIVE STRIDES IN BUILDING THE MODEL, STRUCTURE, AND NETWORK TO POWER ITS VISION BY: -EXPANDING THE NETWORK OF EXPERTS WITH ADVISORS FROM NESTLE-PURINA AND THE AMERICAN KENNEL CLUB. PROVIDING MENTORING AND SUPPORT TO START-UPS THROUGH SOCIAL VENTURE STUDIO, UMKC'S TECHNOLOGY VENTURES STUDIO AND AGLAUNCH PROGRAMS. -ESTABLISHING LEGAL ENTITIES AND ITS MANAGEMENT STRUCTURE. -ADVANCING SEVERAL EARLY-STAGE COMPANIES TOWARDS POTENTIAL INVESTMENT. -INCORPORATING INDUSTRY BEST PRACTICES TO ENSURE DIVERSITY, EQUITY, AND INCLUSION IN OPERATIONS AND PORTFOLIO INVESTMENTS. THE KC NEXUS FUND TEAM PROVIDES MENTORING, GUIDANCE AND CONNECTIONS THAT AID IN CREATING QUALITY LIFE SCIENCES INVESTMENT OPPORTUNITIES FOR REGIONAL INVESTORS AND LIFE SCIENCES COMPANIES. 10. WORKFORCE DEVELOPMENT BIONEXUS KC CONTINUES TO AMPLIFY EFFORTS TO BRING MORE ENGAGEMENT BETWEEN ORGANIZATIONS, INDUSTRY AND EDUCATORS, AND THE ECOSYSTEM. BIONEXUS KC PARTNERS WITH OTHER REGIONAL ORGANIZATIONS TO PROMOTE STEM LEARNING AND BUILD AWARENESS OF CAREERS IN LIFE SCIENCES AMONG ELEMENTARY, MIDDLE, AND HIGH SCHOOL, UNDERGRADUATE, AND GRADUATE STUDENTS. PREP-KC BIONEXUS KC MET WITH PREP-KC LEADERSHIP QUARTERLY AND PARTICIPATED IN PROGRAMMING AIMED AT BOTH STUDENTS AND ADMINISTRATORS. IN 2022, BIONEXUS KC PRESIDENT AND CEO, DENNIS RIDENOUR, JOINED A CAREER PANEL DISCUSSION AS PART OF THE PREP-KC LAUNCH OF THEIR DATA SCIENCE INITIATIVE. BIOKANSAS BIONEXUS KC PROVIDED SCHOLARSHIPS FOR 50 AREA HIGH SCHOOL STUDENTS TO ATTEND THE BIOKANSAS MECHANISMS OF DISEASE RESEARCH AND RECRUITMENT CONFERENCE AS PART OF THE INAUGURAL INNOVATION FESTIVAL. THIS NOVEL CONFERENCE MATCHED EARLY CAREER SCIENTISTS WITH REGIONAL COMPANIES AND INSTITUTIONS, AND EXPOSED THE STUDENTS TO ENGAGING PRESENTATIONS AND WORKSHOPS, AS WELL AS NETWORKING OPPORTUNITIES. GREATER KANSAS CITY SCIENCE AND ENTERTAINMENT FAIR BIONEXUS KC SPONSORED THE 71ST ANNUAL FAIR, WHICH WAS HOSTED VIRTUALLY. IN ADDITION TO THE SPONSORSHIP, BIONEXUS KC LEADERSHIP JUDGED STUDENT POSTERS AND HELPED IDENTIFY TOP ENTRIES. KC STEM ALLIANCE BIONEXUS KC HAS SUPPORTED THE KC STEM ALLIANCE IN ITS WORK TO DEVELOP A REGIONAL, FORMALIZED STEM LEARNING ECOSYSTEM SINCE ITS INCEPTION IN 2015. STEM CONNECT-KC IS AN OPEN, COLLABORATIVE NETWORK THAT SHIFTS THE TRADITIONAL FOCUS FROM THINKING OF EDUCATION AS ONE LEARNING INSTITUTION (SCHOOLS) TO FOCUSING ON THE LEARNER AND PLACES WHERE LEARNING HAPPENS SUCH AS MUSEUMS, LIBRARIES, AFTERSCHOOL PROGRAMS, AND AT HOME. AS PART OF THE STEM CONNECT-KC LEADERSHIP TEAM, BIONEXUS KC AIDS IN PROVIDING LEADERSHIP TO REGIONAL INITIATIVES THAT FOCUS ON IMPROVING QUALITY, ACCESS, AND EQUITY TO STEM PROGRAMS FOR ALL STUDENTS. PROJECT LEAD THE WAY BIONEXUS KC LEADERSHIP PARTICIPATED AS VALIDATION JUDGES FOR THE KC STEM ALLIANCE PROJECT LEAD THE WAY SENIOR SHOWCASE, TO IDENTIFY AND AWARD TOP PRIZES FOR THE BIOMEDICAL RESEARCH COMPETITION 11. FOCUS FORWARD ON THE FUTURE OF KC ON OCTOBER 20, 2022, BIONEXUS KC HOSTED NEARLY 500 LEADERS AND STUDENTS AT THE MIDLAND THEATRE FOR THE FIRST TIME SINCE 2019 TO FOCUS FORWARD ON THE FUTURE OF HEALTHCARE INNOVATION IN KC AND HOW THE REGION CAN MULTIPLY ITS IMPACT. THE PURPOSE OF THIS EVENT WAS TO CONVENE THE REGION'S BRIGHTEST MINDS TO SHARE OUR ACCOMPLISHMENTS, CONNECT THE COMMUNITY, AND PROMOTE COLLABORATION TO ADVANCE ANIMAL AND HUMAN HEALTH. THE EVENT FEATURED DAVID FAJGENBAUM, MD, MBA, MSC, ASSISTANT PROFESSOR OF MEDICINE AT THE UNIVERSITY OF PENNSYLVANIA, AND EXECUTIVE DIRECTOR OF THE CASTLEMAN DISEASE COLLABORATIVE NETWORK. AT 25 YEARS OLD, WHILE IN MEDICAL SCHOOL, HE FELL CRITICALLY ILL, AND HIS DOCTORS COULD NOT FORM 990, PART III, LINE 4A IDENTIFY THE CAUSE. DR. FAJGENBAUM IS THE NATIONAL BESTSELLING AUTHOR OF 'CHASING MY CURE: A DOCTOR'S RACE TO TURN HOPE INTO ACTION AND A PATIENT BATTLING IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE (IMCD). HE IS IN HIS LONGEST REMISSION EVER THANKS TO A PRECISION TREATMENT THAT HE IDENTIFIED, WHICH HAD NEVER BEEN USED BEFORE FOR IMCD. HE ALSO LAUNCHED EVERY CURE, A NONPROFIT DEVOTED TO SAVING LIVES BY REPURPOSING EXISTING DRUGS. LEADERS FROM BIONEXUS KC COMMITTEES SHARED THEIR VISION OF THE FUTURE FOR THE LIFE SCIENCES COMMUNITY AND THE AUDIENCE EXPRESSED THEIR PERSPECTIVE ON THE VALUE OF BIONEXUS KC VIA A WORD-CLOUD. 12. "SCIENCE2ART" SCIENCE2ART IS A PLATFORM FOR REGIONAL SCIENTISTS TO DISPLAY AND DESCRIBE THEIR RESEARCH THROUGH THE VISUAL ARTS. EACH OF THESE REMARKABLE PIECES TOLD A PERSONAL RESEARCH STORY AND POETICALLY CAPTURES THE FIELDWORK PERFORMED BY THE SCIENTISTS AND THEIR TEAMS. THESE IMAGES WERE SUBMITTED BY SCIENTISTS FROM COLUMBIA, MISSOURI, TO MANHATTAN, KANSAS. THE 2022 SCIENCE2ART PROGRAM WAS PRESENTED IN TWO PHASES. THE FIRST PHASE WAS AN EXHIBIT IN THE LINDA HALL LIBRARY AND THE SECOND PHASE WAS THE AUCTION AT THE BIONEXUS KC ANNUAL EVENT. ALL PROCEEDS FROM THE SCIENCE2ART AUCTION WERE MATCHED BY BIONEXUS KC AND USED TO SUPPORT STEAM EDUCATION IN KC FOLLOWS: -HIGH SCHOOL PARTICIPATION IN 2022 INNOVATION FESTIVAL'S MECHANISM OF DISEASE RESEARCH AND RECRUITMENT CONFERENCE ORGANIZED BY BIOKANSAS. -PREP-KC -SCIENCE CITY AND THE GREATER KANSAS CITY SCIENCE & ENGINEERING FAIR -FREE EDUCATIONAL PROGRAMS AT THE KEMPER MUSEUM OF CONTEMPORARY ART 13. EVENTS -NEXUS INFORMATICS IN PARTNERSHIP WITH CHILDREN'S MERCY, HOSPITAL BIONEXUS KC HOSTED THE 2022 ANNUAL "NEXUS INFORMATICS CONFERENCE" AT KANSAS CITY UNIVERSITY, WHICH FEATURED A UNIQUE BLEND OF INFORMATICS PERSPECTIVES AND EXPERTISE INDUSTRY, ACADEMIA, MEDICINE, AGRICULTURE, TECHNOLOGY, AND BIOLOGY A TRUE "NEXUS." THE TWO-DAY EVENT GATHERED NATIONAL DATA SCIENCE LEADERS WITH REGIONAL RESEARCHERS, INDUSTRY PROFESSIONALS, AND STUDENTS, CONSISTING OF 10-MINUTE, HIGH-TEMPO, SCIENTIFIC PRESENTATIONS INTERSPERSED WITH NETWORKING OPPORTUNITIES AND A CAREER PANEL. KEYNOTE SPEAKERS INCLUDED WENDY MARIE INGRAM, PHD, CHIEF EXECUTIVE OFFICER AT DRAGONFLY MENTAL HEALTH AND DAN JACOBSON, PHD, CHIEF SCIENTIST, COMPUTATIONAL SYSTEMS BIOLOGY AT OAK RIDGE NATIONAL LABORATORY. INGRAM'S PRESENTATION FOCUSED ON SUPPORTING AND SUSTAINING INCREDIBLE MINDS AND TALENT IN INFORMATICS AND THE STIGMA SURROUNDING MENTAL HEALTH. JACOBSON SHARED HIS RESEARCH IN AGRICULTURE, HUMAN HEALTH, AND IMAGE-BASED PHENOTYPING. THE APRIL 7 8, 2022 CONFERENCE ENCOURAGED CONNECTIONS AND NEW COLLABORATIONS AND HAD A RECORD-HIGH NUMBER OF ATTENDEES, SPEAKERS, AND STUDENT RESEARCH POSTERS EMPHASIZING THE WEALTH OF INFORMATICS INTEREST, CAPABILITIES, AND EXPERTISE IN THE KC REGION. -ONE HEALTH DAY BIONEXUS KC PARTNERED WITH KANSAS STATE UNIVERSITY, KU EDWARDS CAMPUS AND THE UNIVERSITY OF KANSAS MEDICAL CENTER FOR THE NOVEMBER 1, 2022 "KANSAS CITY ONE HEALTH DAY." THIS EVENT IS PART OF AN ANNUAL, INTERNATIONAL EVENT FOCUSED ON COMPLEX COLLABORATIONS ACROSS MULTIPLE DISCIPLINES TO ACHIEVE OPTIMAL HEALTH FOR PEOPLE, ANIMALS, AND THE ENVIRONMENT REFERRED TO AS ONE HEALTH. THE 2022 KC ONE HEALTH DAY'S TOPIC WAS 'MICROPLASTICS,' AN EMERGING CONCERN FOR HUMAN, ANIMAL, AND ENVIRONMENTAL HEALTH. MICROPLASTICS ARE FINE PARTICLES OF PLASTIC (SMALLER THAN ONE MILLIMETER) FOUND IN STREAMS, LAKES, OCEANS, SOIL, AND EVEN AIRBORNE DUST. THEY ARE EVERYWHERE, EVEN THOUGH THEY CAN'T BE SEEN, BUT SUBSTANTIAL RESEARCH REMAINS TO DETERMINE MICROPLASTIC'S SEVERITY AND EFFECTS. THIS EVENT FEATURED A SYNOPSIS OF MICROPLASTICS AND THEIR INFLUENCE ON "ONE HEALTH" BY KEYNOTE BELINDA STRUM, FROM THE UNIVERSITY OF KANSAS. THE PROGRAM ALSO HIGHLIGHTED THE IMPACT MICROPLASTICS HAVE ON AGRICULTURE, THE FOOD WE CONSUME, AND HOW EXPOSURE TO CHEMICALS IN PLASTICIZERS IMPACTS HUMAN HEALTH. THE EVENT HOSTED OVER 100 ACADEMIC AND INDUSTRY ATTENDEES AND FEATURED A POSTER COMPETITION FOR HIGH SCHOOL, UNDERGRADUATE, AND GRADUATE STUDENTS TO COMPETE FOR A CASH SCHOLARSHIP. 14. SOCIAL MEDIA BIONEXUS KC SERVES AS A RESOURCE FOR LIFE SCIENCES NEWS FROM MANHATTAN TO COLUMBIA, USING THE FOLLOWING COMMUNICATION TOOLS: -CONNECTION BLOG: HTTPS://BIONEXUSKC.ORG/CATEGORY/THE-CONNECTION/ -EXPERT EXCHANGE VIDEO SERIES: HTTPS://BIONEXUSKC.ORG/VIDEO_CATEGORY/EXPERT-EXCHANGE/ FORM 990, PART VI, SECTION B, LINE 11B THE ORGANIZATION HAS A POLICY FOR THE ORGANIZATION'S AUDIT COMMITTEE TO REVIEW THE 990 BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C ALL STAFF AND DIRECTORS MUST SUBMIT ANY CONFLICTS OF INTEREST ON AN ANNUAL BASIS. IF A CONFLICT ARISES WITHIN THE BOARD, THE DISCLOSING INDIVIDUAL SHALL NEITHER VOTE NOR ENDEAVOR TO INFLUENCE THE DECISION. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION OF THE ORGANIZATION'S PRESIDENT IS AGREED UPON BY THE BOARD OF DIRECTORS AND FINALIZED VIA A WRITTEN EMPLOYMENT CONTRACT. THIS APPROVAL IS DOCUMENTED IN THE MINUTES OF THE BOARD. IN 2013 THE ORGANIZATION CREATED A COMPENSATION COMMITTEE AND CONDUCTED A COMPENSATION STUDY TO FURTHER REFINE THE COMPENSATION PROCESS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE ONLY AVAILABLE UPON REQUEST. FORM 990, PART XII, LINE 1 THE ORGANIZATION UTILIZES THE MODIFIED CASH BASIS OF ACCOUNTING. UNDER THIS METHOD OF ACCOUNTING, PROPERTY AND EQUIPMENT IS CAPITALIZED AS AN ASSET ON THE STATEMENTS OF ASSETS AND NET ASSETS - MODIFIED CASH BASIS, AND DEPRECIATION EXPENSE AND GAINS AND LOSSES ON DISPOSAL OF PROPERTY AND EQUIPMENT ARE RECORDED ON THE STATEMENTS OF REVENUES, EXPENSES AND CHANGES IN NET ASSETS - MODIFIED CASH BASIS. ADDITIONALLY, INVESTMENTS ARE RECORDED AS AN ASSET ON THE STATEMENTS OF ASSETS AND NET ASSETS - MODIFIED CASH BASIS, AND GAINS AND LOSSES RELATED TO THE INVESTMENTS ARE RECORDED ON THE STATEMENTS OF REVENUES, EXPENSES AND CHANGES IN NET ASSETS - MODIFIED CASH BASIS. ALL OTHER ELEMENTS OF THE FINANCIAL STATEMENTS ARE MAINTAINED ON THE CASH BASIS OF ACCOUNTING. FORM 990, PART XXII, LINE 2C THE ORGANIZATION HAS AN AUDIT COMMITTEE CHARGES WITH FINANCIAL STATEMENT REVIEW.